Expansion of Single Cell Transcriptomics Data of SARS-CoV Infection in Human Bronchial Epithelial Cells to COVID-19.

Bronchial epithelial cells COVID-19 Cytokine storm Gene ontology Immunological regulations Reactome pathways SARS-CoV-2 Severe acute respiratory syndrome Signaling pathways Transcriptomics

Journal

Biological procedures online
ISSN: 1480-9222
Titre abrégé: Biol Proced Online
Pays: England
ID NLM: 100963717

Informations de publication

Date de publication:
2020
Historique:
received: 13 05 2020
accepted: 21 06 2020
entrez: 6 8 2020
pubmed: 6 8 2020
medline: 6 8 2020
Statut: epublish

Résumé

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 19 (COVID-19) that was emerged as a new member of coronaviruses since December 2019 in Wuhan, China and then after was spread in all continentals. Since SARS-CoV-2 has shown about 77.5% similarity to SARS-CoV, the transcriptome and immunological regulations of SARS-CoV-2 was expected to have high percentage of overlap with SARS-CoV. In this study, we applied the single cell transcriptomics data of human bronchial epithelial cells (2B4 cell line) infected with SARS-CoV, which was annotated in the Expression Atlas database to expand this data to COVID-19. In addition, we employed system biology methods including gene ontology (GO) and Reactome pathway analyses to define functional genes and pathways in the infected cells with SARS-CoV. The transcriptomics analysis on the Expression Atlas database revealed that most genes from infected 2B4 cell line with SARS-CoV were downregulated leading to immune system hyperactivation, induction of signaling pathways, and consequently a cytokine storm. In addition, GO:0016192 (vesicle-mediated transport), GO:0006886 (intracellular protein transport), and GO:0006888 (ER to Golgi vesicle-mediated transport) were shown as top three GOs in the ontology network of infected cells with SARS-CoV. Meanwhile, R-HAS-6807070 (phosphatase and tensin homolog or PTEN regulation) showed the highest association with other Reactome pathways in the network of infected cells with SARS-CoV. PTEN plays a critical role in the activation of dendritic cells, B- and T-cells, and secretion of proinflammatory cytokines, which cooperates with downregulated genes in the promotion of cytokine storm in the COVID-19 patients. Based on the high similarity percentage of the transcriptome of SARS-CoV with SARS-CoV-2, the data of immunological regulations, signaling pathways, and proinflammatory cytokines in SARS-CoV infection can be expanded to COVID-19 to have a valid platform for future pharmaceutical and vaccine studies.

Sections du résumé

BACKGROUND BACKGROUND
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 19 (COVID-19) that was emerged as a new member of coronaviruses since December 2019 in Wuhan, China and then after was spread in all continentals. Since SARS-CoV-2 has shown about 77.5% similarity to SARS-CoV, the transcriptome and immunological regulations of SARS-CoV-2 was expected to have high percentage of overlap with SARS-CoV.
RESULTS RESULTS
In this study, we applied the single cell transcriptomics data of human bronchial epithelial cells (2B4 cell line) infected with SARS-CoV, which was annotated in the Expression Atlas database to expand this data to COVID-19. In addition, we employed system biology methods including gene ontology (GO) and Reactome pathway analyses to define functional genes and pathways in the infected cells with SARS-CoV. The transcriptomics analysis on the Expression Atlas database revealed that most genes from infected 2B4 cell line with SARS-CoV were downregulated leading to immune system hyperactivation, induction of signaling pathways, and consequently a cytokine storm. In addition, GO:0016192 (vesicle-mediated transport), GO:0006886 (intracellular protein transport), and GO:0006888 (ER to Golgi vesicle-mediated transport) were shown as top three GOs in the ontology network of infected cells with SARS-CoV. Meanwhile, R-HAS-6807070 (phosphatase and tensin homolog or PTEN regulation) showed the highest association with other Reactome pathways in the network of infected cells with SARS-CoV. PTEN plays a critical role in the activation of dendritic cells, B- and T-cells, and secretion of proinflammatory cytokines, which cooperates with downregulated genes in the promotion of cytokine storm in the COVID-19 patients.
CONCLUSIONS CONCLUSIONS
Based on the high similarity percentage of the transcriptome of SARS-CoV with SARS-CoV-2, the data of immunological regulations, signaling pathways, and proinflammatory cytokines in SARS-CoV infection can be expanded to COVID-19 to have a valid platform for future pharmaceutical and vaccine studies.

Identifiants

pubmed: 32754004
doi: 10.1186/s12575-020-00127-3
pii: 127
pmc: PMC7377208
doi:

Types de publication

Journal Article

Langues

eng

Pagination

16

Informations de copyright

© The Author(s) 2020.

Déclaration de conflit d'intérêts

Competing InterestsThe authors declare that they have no conflict of interests.

Références

Arch Virol. 2020 Apr;165(4):809-822
pubmed: 32103340
Nat Med. 2020 May;26(5):640-642
pubmed: 32273610
PLoS Comput Biol. 2017 May 18;13(5):e1005457
pubmed: 28545146
Lancet. 2004 Jan 17;363(9404):203-9
pubmed: 14738793
Int J Oncol. 2017 Sep;51(3):791-800
pubmed: 28677801
Immunity. 2015 Aug 18;43(2):331-42
pubmed: 26253785
Gene. 2016 Dec 5;594(1):144-150
pubmed: 27623506
Nat Microbiol. 2019 Apr;4(4):683-692
pubmed: 30718850
PLoS Negl Trop Dis. 2013;7(3):e2107
pubmed: 23516652
J Am Heart Assoc. 2020 Jun 16;9(12):e016887
pubmed: 32463308
Immunity. 2016 Sep 20;45(3):597-609
pubmed: 27590115
Int J Biomed Sci. 2005 Jun;1(1):46-52
pubmed: 23674953
Virus Res. 2014 Dec 19;194:124-37
pubmed: 25093995
J Infect Dis. 2018 Nov 22;218(suppl_5):S486-S495
pubmed: 30476250
BMC Bioinformatics. 2019 Dec 23;20(Suppl 21):704
pubmed: 31865910
Nat Commun. 2020 May 4;11(1):2251
pubmed: 32366817
PLoS One. 2010 Jan 15;5(1):e8729
pubmed: 20090954
Cancer Lett. 2011 Nov 1;310(1):35-45
pubmed: 21763068
Vaccines (Basel). 2017 Sep 20;5(3):
pubmed: 28930167
J Nutr. 2006 Jun;136(6 Suppl):1660S-1665S
pubmed: 16702336
Hereditas. 2019 Feb 6;156:10
pubmed: 30774581
Genome Med. 2016 May 03;8(1):53
pubmed: 27142060
PLoS One. 2016 Aug 16;11(8):e0160970
pubmed: 27529750
Immunology. 2003 Jun;109(2):263-70
pubmed: 12757622
Crit Care. 2011;15(1):R4
pubmed: 21211006
J Biol Chem. 2017 Apr 21;292(16):6600-6620
pubmed: 28235804
Int J Mol Sci. 2019 Jun 02;20(11):
pubmed: 31159473
J Amino Acids. 2014;2014:783730
pubmed: 24660059
Genet Res (Camb). 2019 Dec 27;101:e14
pubmed: 31878985
Front Microbiol. 2018 Jun 05;9:1067
pubmed: 29922247
J Pharm Bioallied Sci. 2012 Aug;4(Suppl 2):S310-2
pubmed: 23066278
J Clin Virol. 2020 Jun;127:104370
pubmed: 32344321
Immunology. 2018 Feb;153(2):171-178
pubmed: 28921535
J Immunol. 2004 Jun 15;172(12):7841-7
pubmed: 15187168
Curr Opin Microbiol. 2007 Jun;10(3):297-302
pubmed: 17574903
Stem Cell Reports. 2018 Apr 10;10(4):1384-1397
pubmed: 29641991
Cell J. 2019 Jan;20(4):604-607
pubmed: 30124010
Viruses. 2018 Dec 17;10(12):
pubmed: 30562987
Euro Surveill. 2020 Jan;25(4):
pubmed: 32019669
mBio. 2013 Apr 30;4(3):e00165-13
pubmed: 23631916
J Virol. 2007 Mar;81(5):2418-28
pubmed: 17166901
Biol Proced Online. 2020 Apr 21;22:8
pubmed: 32336957
Genome Res. 2008 Sep;18(9):1509-17
pubmed: 18550803
J Anim Sci Biotechnol. 2013 Jul 30;4(1):27
pubmed: 23899038
NPJ Vaccines. 2019 Dec 18;4:53
pubmed: 31871773
Front Biol (Beijing). 2017 Jun;12(3):163-174
pubmed: 29527223
Biochim Biophys Acta. 2005 Jun 30;1741(1-2):4-10
pubmed: 15916886
Expert Rev Anti Infect Ther. 2016;14(3):285-97
pubmed: 26760927
J Biol Chem. 2016 Mar 4;291(10):5342-54
pubmed: 26769965
Virol J. 2005 Aug 22;2:69
pubmed: 16115318
Biochem J. 2004 Oct 1;383(Pt 1):13-8
pubmed: 15294014
J Biol Chem. 2006 Apr 21;281(16):10983-9
pubmed: 16446363
Virol J. 2014 Apr 24;11:75
pubmed: 24762043
Asia Pac J Ophthalmol (Phila). 2020 Mar-Apr;9(2):85-87
pubmed: 32349115
J Travel Med. 2020 Mar 13;27(2):
pubmed: 32052846
Arch Virol. 2005 May;150(5):1023-31
pubmed: 15645376
Medicine (Baltimore). 2016 Feb;95(5):e2606
pubmed: 26844470
BMJ. 2020 May 11;369:m1851
pubmed: 32393532
Nat Commun. 2020 Mar 27;11(1):1620
pubmed: 32221306
Diseases. 2016 Jul 25;4(3):
pubmed: 28933406
Biol Proced Online. 2020 Jun 19;22:11
pubmed: 32572334
Acta Neuropathol Commun. 2018 May 30;6(1):40
pubmed: 29848386
Lancet Infect Dis. 2020 Apr 17;:
pubmed: 32311322
Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):972-7
pubmed: 11805339
Front Immunol. 2017 Dec 18;8:1839
pubmed: 29326715
Nucleic Acids Res. 2020 Jan 8;48(D1):D77-D83
pubmed: 31665515
Sci Rep. 2017 Mar 03;7:43751
pubmed: 28256586
Sci Rep. 2019 Jan 18;9(1):213
pubmed: 30659199
J Virol. 2019 May 15;93(11):
pubmed: 30867313
J Virol. 2006 Jan;80(2):785-93
pubmed: 16378980
Nat Rev Genet. 2015 Jan;16(1):57-66
pubmed: 25446315
PLoS One. 2013 May 01;8(5):e62149
pubmed: 23658707
Cell. 1994 Sep 23;78(6):1039-49
pubmed: 7923354

Auteurs

Reza Zolfaghari Emameh (R)

Department of Energy and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), 14965/161, Tehran, Iran.

Hassan Nosrati (H)

Department of Materials Engineering, Tarbiat Modares University, Tehran, Iran.

Mahyar Eftekhari (M)

Department of Energy and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), 14965/161, Tehran, Iran.

Reza Falak (R)

Immunology Research Center, Iran University of Medical Sciences, Tehran, Iran.
Immunology Department, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Majid Khoshmirsafa (M)

Immunology Research Center, Iran University of Medical Sciences, Tehran, Iran.
Immunology Department, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Classifications MeSH